Impact of early versus late administration of bamlanivimab on readmissions in patients with high-risk COVID-19.
Melton JD 3rd, Wilson K, Blind F, Barbera A, Bhisitkul D, Hasara S, Homa K, Karp J, Escowitz H, Haber T, DeGroot D, Anderson J, DeLeon J, Santos JL, Faviere D, Fuell J, Gillespie R, Glueck J, Reeber C, Rhodes DJ, Rodriguez V.
Melton JD 3rd, et al.
Am J Emerg Med. 2021 Dec;50:437-441. doi: 10.1016/j.ajem.2021.08.032. Epub 2021 Aug 16.
Am J Emerg Med. 2021.
PMID: 34487951
Free PMC article.